Oral Cancer (Squamous Cell Carcinoma of the Oral Cavity)
Persistent oral ulcer, mass, or red/white patch in a smoker or heavy drinker — biopsy any lesion not healed in 2 weeks.
Also known as: oral cancer, oral squamous cell carcinoma, oral SCC, tongue cancer, floor of mouth cancer
Overview
Malignancy arising from the mucosa of the oral cavity, including the lips, anterior two-thirds of the tongue, buccal mucosa, floor of mouth, hard palate, gingiva, and retromolar trigone. More than 90% are squamous cell carcinomas.
Epidemiology
Roughly 35,000-55,000 new oral and oropharyngeal cancer cases annually in the United States; male predominance roughly 2-3:1; median age at diagnosis approximately 63. The tongue (lateral border) and floor of the mouth are the most common subsites. Five-year survival is highly stage-dependent: greater than 80% for localized disease but less than 40% for regional or distant disease.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Oral Cancer (Squamous Cell Carcinoma of the Oral Cavity) outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Tobacco use (cigarettes, cigars, pipe, smokeless tobacco) — strongest modifiable risk factor
- Heavy alcohol use (synergistic with tobacco)
- Betel nut chewing
- HPV — primarily associated with oropharyngeal SCC (tonsil, base of tongue) rather than true oral cavity SCC, but increasingly relevant
- Sun exposure (lip cancer)
- Premalignant lesions: leukoplakia, erythroplakia, oral lichen planus, submucous fibrosis
- Immunosuppression (transplant, HIV)
- Prior head and neck radiation
Pathophysiology
Chronic mucosal exposure to carcinogens drives a stepwise accumulation of mutations (TP53, CDKN2A, NOTCH1, PIK3CA) through hyperplasia, dysplasia, carcinoma in situ, and invasive carcinoma. Lymphatic spread to cervical nodes is common; the depth of invasion correlates with the risk of nodal metastasis and prognosis.
Clinical presentation
Symptoms
- Non-healing oral ulcer or mass present for more than 2-3 weeks
- Persistent oral pain, often dull and progressively worse
- Bleeding, loose teeth, or ill-fitting dentures
- Otalgia (referred pain via the auriculotemporal branch of CN V3 and via CN IX/X)
- Dysphagia, odynophagia, trismus suggests advanced disease
- Neck mass (cervical lymphadenopathy) may be the presenting sign
Signs / physical exam
- Indurated ulcer with rolled, raised, irregular borders
- Red, white, or mixed (erythroleukoplakic) patch that does not wipe off
- Exophytic or endophytic mass, especially on the lateral tongue or floor of mouth
- Palpable firm, fixed cervical lymphadenopathy (levels I-III most often)
- Reduced tongue mobility or numbness in a trigeminal distribution
- Trismus suggests pterygoid invasion
Classic findings
Persistent, painless, indurated ulcer on the lateral tongue or floor of mouth in a smoker.
Differential diagnosis
- Aphthous ulcer — Small, painful, round ulcer with white pseudomembrane and erythematous halo; self-limited within 2 weeks
- Traumatic ulcer — History of biting or denture trauma; resolves once the trauma is removed
- Herpetic ulcers — Multiple small vesicles that coalesce; keratinized mucosa primarily; recurrent; vesicular phase distinguishes
- Oral lichen planus — Bilateral lace-like white striae (Wickham) or erosive plaques; chronic and symmetrical; biopsy if atypical or persistent
- Leukoplakia and erythroplakia (premalignant) — Painless white or red mucosal patches that cannot be wiped off; high malignant transformation rate for erythroplakia
- Necrotizing sialometaplasia — Sudden palatal ulcer in a smoker or after dental procedure; benign and self-resolving but mimics SCC histologically
- Salivary gland tumor or minor salivary gland malignancy — Submucosal mass without surface ulceration; biopsy
- Syphilitic chancre or gumma — Painless ulcer; serology (RPR, treponemal tests)
Diagnostic workup
Diagnostic criteria
Histologic confirmation by incisional or excisional biopsy. Staging follows AJCC 8th edition TNM system, incorporating depth of invasion and extranodal extension.
Labs
- CBC, comprehensive metabolic panel, coagulation studies, type and screen for preoperative planning
- HPV/p16 testing of biopsy tissue (although primarily relevant for oropharyngeal SCC, increasingly studied in oral cavity SCC)
- Nutritional assessment (albumin, prealbumin) if weight loss
Imaging
- Direct visualization and incisional biopsy of suspicious lesions — biopsy any lesion that has not healed within 2-3 weeks
- Contrast-enhanced CT of neck — primary staging modality for tumor extent and cervical nodes
- MRI of the primary site for soft tissue and perineural invasion (preferred for tongue and floor of mouth)
- PET/CT for staging in advanced disease and to assess for distant metastasis or second primary
- Panoramic radiograph for mandibular involvement
- Examination under anesthesia with panendoscopy to evaluate for synchronous second primary lesions
Diagnostic algorithm
flowchart TD
A[Suspicious oral lesion<br/>not healed at 2-3 weeks] --> B[Incisional biopsy]
B --> C{SCC confirmed?}
C -->|No| D[Treat alternative cause<br/>re-examine 2-4 weeks]
C -->|Yes| E[CT neck + MRI<br/>+ PET/CT if advanced]
E --> F{Stage}
F -->|I-II| G[Surgery ± selective<br/>neck dissection]
F -->|III-IVA/B| H[Surgery + adjuvant<br/>(chemo)radiation]
F -->|IVC| I[Systemic therapy<br/>palliative care]
G --> J[Surveillance per NCCN]
H --> JTreatment
First-line
- Surgical resection of the primary lesion with adequate margins (typically 1 cm clinically, with frozen-section margins) — mainstay for early-stage disease
- Neck dissection (selective or modified radical) for clinically positive nodes or for primary tumors with significant depth of invasion (generally greater than 3-4 mm)
- Postoperative radiation therapy (with or without concurrent platinum-based chemotherapy) for advanced T-stage, positive or close margins, extranodal extension, perineural invasion, or multiple positive nodes
Second-line / adjunct
- Reconstruction (radial forearm, fibula, or anterolateral thigh free flaps) for functional preservation
- Speech and swallowing therapy, dental rehabilitation
- Smoking and alcohol cessation counseling
- Surveillance per NCCN: clinical exam every 1-3 months in year 1, every 2-6 months in year 2, every 4-8 months in years 3-5, then annually
Complications
- Locoregional recurrence (highest risk in the first 2 years)
- Second primary head and neck or lung malignancy
- Chronic dysphagia, aspiration, xerostomia after radiation
- Osteoradionecrosis of the mandible
- Disfigurement and speech impairment
- Cervical lymphedema
- Nutritional decline and weight loss
PANCE pearls
- Biopsy any oral lesion that has not healed in 2-3 weeks — do not assume aphthous ulcer.
- The lateral tongue and floor of the mouth are the highest-risk subsites.
- Erythroplakia carries the highest malignant transformation risk of premalignant lesions.
- Refer any persistent neck mass in an adult older than 40 with risk factors for prompt workup — assume metastatic SCC until proven otherwise.
- Tobacco and alcohol cessation reduces second primary risk substantially.
References
- NCCN — NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (current version)
- AAO-HNS — American Academy of Otolaryngology-Head and Neck Surgery resources on oral cavity malignancy
- AJCC — AJCC Cancer Staging Manual, 8th edition (Amin et al., Springer 2017)
Practice EENT questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.